DGAP-News: RHÖN-KLINIKUM AG (english)
RHÖN-KLINIKUM AG: Result Press Conference in Frankfurt/MainRHÖN-KLINIKUM AG / Final Results/Results Forecast
19.04.2007
Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
RHÖN-KLINIKUM AG, Bad Neustadt/Saale:
- Results Press Conference in Frankfurt/Main -
Results for financial year 2006
Success story continued
Integration of Universitätsklinikum Gießen und Marburg successfully
implemented
Revenue raised by 36.5% to EUR 1.9 billion
Consolidated profit raised by 23.5 % to EUR 109.1 million
Total of 1,394,035 patients treated at the Group's 45 hospitals
30,409 employees as at year-end 2006
Forecast for the further course of 2007
Market environment and future prospects
Continuation of growth strategy with sound economic judgment
Revenues of EUR 2 billion forecast for 2007, and forecast for 2007 net
consolidated profit raised from EUR 100 million to EUR 102 million
Bad Neustadt a.d. Saale/Frankfurt am Main, 19 April 2007 ----- At its
annual Results Press Conference held today in Frankfurt am Main the Board
of Management of the listed hospital group with headquarters in the Rhön
confirmed the trend figures already published in February and thus its own
forecasts. 'RHÖN-KLINIKUM AG thus continues the success story seen since
1988 - despite the difficult economic environment of doctors' strikes and
reform debates', said Wolfgang Pföhler, chairman of the Board of Management
of the hospital group. The integration of Universitätsklinikum Gießen und
Marburg was successfully implemented.
The first-time consolidation of the largest acquisition in the Company's
history, Universitätsklinikum Gießen und Marburg (consolidated as at 1
February 2006), as well as that of Frankenwaldklinik in Kronach and Heinz
Kalk-Krankenhaus in Bad Kissingen (both facilities from 1 January 2006),
resulted in a 36.5% surge in revenues and thus in consolidated revenue of EUR
1.933 billion (previous year: EUR 1.416 billion). With the rise in net
consolidated profit by EUR 20.8 million (+23.5 %) to EUR 109.1 million
(previous year: EUR 88.3 million), the Group's expectations were met. The
result was marked by two extraordinary effects of opposite signs: a
one-off, tax-relieving effect (amendment of Section 37 (5) Corporation Tax
Act) as well as the burdening effect from the net loss for the year
recorded at Universitätsklinikum Gießen und Marburg.
According to the Group's management, the Supervisory Board and the Board
of Management of RHÖN-KLINIKUM AG have decided to waive that part of their
bonus attributable to the extraordinary tax effect. This waiver will take
effect only in the 2007 consolidated financial statements. 'We consider it
reasonable and appropriate to be paid for our own performance, and not to
profit from one-off tax effects', Wolfgang Pföhler stated. 'For 2007 we
therefore raise our forecast for net consolidated profit to EUR 102 million.'
EBITDA (earnings before interest, depreciation/amortisation and tax) rose
by 6.9% to reach EUR 221.1 million (previous year: EUR 206.9 million).
Operating earnings EBIT rose by EUR 6.0 million to EUR 146.1 million (previous
year: EUR 140.1 million). This includes the net loss for the year of EUR 8.4
million recorded at the hospitals in Gießen, Marburg, Kronach and Bad
Kissingen consolidated for the first time in 2006. The facilities already
consolidated before 2006 together reported EBIT growth of EUR 14.4 million
and an EBIT margin of 12.3% (previous year: 11.9%). 'We have thus succeeded
in countering the deteriorating framework conditions for hospitals',
explained CFO Dietmar Pawlik. EBT (earnings before tax) reached EUR 125.7
million, a gain of 1.8% over the previous year's level (EUR 123.5 million).
Operating cash flow grew 6.0 % to reach EUR 165.0 million (previous year: EUR
155.6 million), which does include the one-off non-cash effect. Earnings
per ordinary share stood at EUR 2.03 (previous year: EUR 1.61).
The 45 hospitals belonging to RHÖN-KLINIKUM Group at year-end 2006 treated
a total of 1,394,035 patients (+46.8%; previous year: 949,376); of these,
526,226 (+28.2%) were treated on an acute inpatient basis, 858,708 (+62.1%)
as outpatients and 9,101 (+1.9%) in the rehab and other areas. The
disproportionate rise in outpatient treatments stems from the university
outpatient units taken over. Excluding the hospitals acquired in 2006,
organic growth in case numbers stood at 3.6%.
At 31 December 2006, the number of employees at the Group (by headcount)
was 30,409 (previous year: 21,226).
Particularly with the takeover of the university hospitals in Gießen and
Marburg, the Group's key ratios have changed significantly in terms of
their structure compared with the previous year. 'The increase in the
personnel cost ratio to 58.3% (previous year: 56.1%) and in the cost of
materials ratio to 25.4% (previous year: 24.3%) essentially stems from the
acquired research and teaching structures. These compared with cost
reimbursements of EUR 15.1 million reported under the item 'Other income'.
Thanks to successful integration and restructuring measures, our personnel
and materials cost ratios at the hospitals already consolidated in 2005
were reduced to a combined ratio of 87.9% (previous year: 88.8%)', Dietmar
Pawlik said.
Forecast for the further course of 2007
'We continue to aim for qualitative growth', explained the chairman of the
Board of Management. The results for the first quarter of 2007 will be
published on Thursday, 3 May 2007 in a separate press release and with the
publication of the interim Q1 2007 report.
On 11 April 2007, the Düsseldorf Court of Appeals dismissed the appeal
lodged against the prohibited sale of the district hospitals in
Rhön-Grabfeld. The judgement has no influence on the growth strategy of
RHÖN-KLINIKUM AG. Over the past two and a quarter years the Group has newly
consolidated 16 hospitals - including the university hospital heavyweights
in Gießen and Marburg. As a result, the company has nearly doubled its
revenues since the cartel proceedings began. 'The situation is annoying,
but does not weigh heavily in economic terms', Wolfgang Pföhler said. The
Board of Management will now review the possibility of appealing to
Germany's Federal High Court of Justice.
'With our proven strategy of 'competence in acquisition and integration' as
well as 'quality before quantity', we will continue to generate viable and
profitable growth', declared a convinced Wolfgang Pföhler. 'We are striving
for generalised healthcare coverage in Germany to high quality standards
for all segments of the population at socially acceptable prices. Not
taking into account potential new acquisitions, our revenues in 2997 will
rise to around EUR 2.0 billion.'
Sallwey & Partner
Brigitte Sallwey
Telemannstr. 18
D-60323 Frankfurt/Main
Tel.: (+49)069-97 203 628
DGAP 19.04.2007
---------------------------------------------------------------------------
Language: English
Issuer: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: fire.ir@rhoen-klinikum-ag.com
www: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Amtlicher Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
Weitere Informationen: www.dpa-AFX.de